LEIDEN JEFFREY M
SEC CIK 1242825 · EDGAR
BoughtSold
Most active insiders at ODTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TPG GP A, LLC | Former 10% Owner | $25.00M | — |
| 2 | Li Nan (LN) | Dir | $20.00M | — |
| 3 | Dimension Capital II, L.P. | Dir | $20.00M | — |
| 4 | SR ONE CAPITAL MANAGEMENT, LLC | 10% | $10.00M | $32.0K |
| 5 | Chu Shelley | Dir | $200.0K | — |
| 6 | LEIDEN JEFFREY M | Dir | $100.0K | — |
| 7 | Haas Jason | CFO | $20.0K | — |
| 8 | Opipari Anthony W. | See Remarks | — | — |
| 9 | Glick Gary D | See Remarks, Dir | — | — |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-11 20:35 | 2026-05-08 | ODTX | Odyssey Therapeutics, Inc. | LEIDEN JEFFREY M | Dir | P - Purchase | $20.00 | +5,000 | 270.2K | +2% | +$100.0K |
| DI | 2026-05-11 20:35 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | LEIDEN JEFFREY M | Dir | C - Cnv Deriv | — | +28.7K | 28.7K | New | — |
| DI | 2026-05-11 20:35 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | LEIDEN JEFFREY M | Dir | M - OptEx | — | +2,963 | 31.7K | +10% | — |
| DI | 2026-05-11 20:35 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | LEIDEN JEFFREY M | Dir | F - Tax | $18.00 | -17 | 31.6K | -0.1% | -$306 |
| 2026-02-26 | 2026-02-24 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $485.11 | -3,547 | 34.8K | -9% | -$1.72M | |
| 2026-02-19 | 2026-02-18 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $483.75 | -2,964 | 38.3K | -7% | -$1.43M | |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +8,269 | 41.3K | +25% | $0 | |
| 2026-01-26 | 2026-01-22 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +9,012 | 33.0K | +38% | $0 | |
| DM | 2025-12-05 | 2025-12-03+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | M - OptEx | $86.52 | +63.8K | 87.8K | +265% | +$5.52M |
| DM | 2025-12-05 | 2025-12-03 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale+OE | $449.20 | -63.8K | 75.2K | -46% | -$28.65M |
| DM | 2025-11-17 | 2025-11-13+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | M - OptEx | $88.59 | +73.3K | 37.9K | New | +$6.49M |
| DM | 2025-11-17 | 2025-11-13+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale+OE | $440.60 | -73.3K | 24.1K | -75% | -$32.29M |
| 2025-02-19 | 2025-02-14 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $463.46 | -6,066 | 24.0K | -20% | -$2.81M | |
| 2025-02-14 | 2025-02-12 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +7,209 | 32.6K | +28% | $0 | |
| 2025-02-14 | 2025-02-13 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $450.83 | -2,525 | 30.1K | -8% | -$1.14M | |
| 2025-02-06 | 2025-02-04 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +15.4K | 25.4K | +154% | $0 | |
| 2024-09-04 | 2024-08-30 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $499.00 | -3,784 | 9,994 | -27% | -$1.89M | |
| 2024-02-21 | 2024-02-20 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $420.58 | -4,118 | 13.8K | -23% | -$1.73M | |
| M | 2024-02-16 | 2024-02-14+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $419.10 | -9,011 | 17.9K | -33% | -$3.78M |
| M | 2024-02-14 | 2024-02-12+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $419.42 | -3,393 | 28.3K | -11% | -$1.42M |
| M | 2024-02-12 | 2024-02-08+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $422.49 | -10.7K | 30.3K | -26% | -$4.54M |
| M | 2024-02-08 | 2024-02-06+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +38.6K | 41.0K | +1,594% | $0 |
| 2024-01-10 | 2024-01-08 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $419.07 | -6,648 | 2,423 | -73% | -$2.79M | |
| M | 2023-12-15 | 2023-12-13 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $399.42 | -13.4K | 9,171 | -59% | -$5.33M |
| 2023-10-18 | 2023-10-16 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $374.00 | -13.0K | 22.4K | -37% | -$4.85M | |
| M | 2023-05-09 | 2023-05-05+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $349.25 | -2,004 | 36.7K | -5% | -$699.9K |
| M | 2023-05-04 | 2023-05-02+ | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $349.98 | -11.0K | 37.4K | -23% | -$3.84M |
| 2023-02-28 | 2023-02-24 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $289.12 | -13.7K | 48.3K | -22% | -$3.97M | |
| 2023-02-14 | 2023-02-13 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $298.26 | -13.3K | 62.1K | -18% | -$3.98M | |
| M | 2023-02-03 | 2023-02-01 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +76.6K | 68.8K | New | $0 |
| 2023-02-03 | 2023-02-02 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $317.83 | -3,578 | 75.4K | -5% | -$1.14M | |
| DM | 2022-07-27 | 2022-07-25 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale+OE | $281.38 | -132.1K | 2,423 | -98% | -$37.16M |
| D | 2022-07-27 | 2022-07-25 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | M - OptEx | $91.05 | +60.3K | 134.5K | +81% | +$5.49M |
| 2022-04-14 | 2022-04-13 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | S - Sale | $289.04 | -15.8K | 74.2K | -18% | -$4.56M | |
| 2022-02-28 | 2022-02-24 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $227.86 | -12.1K | 89.9K | -12% | -$2.77M | |
| 2022-02-22 | 2022-02-17 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $232.51 | -8,236 | 102.1K | -7% | -$1.91M | |
| M | 2022-02-03 | 2022-02-01 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | A - Grant | $0.00 | +66.8K | 99.2K | +207% | $0 |
| 2022-02-03 | 2022-02-02 | VRTX | Vertex Pharmaceuticals | LEIDEN JEFFREY M | Executive COB, Dir | F - Tax | $243.63 | -6,279 | 110.3K | -5% | -$1.53M |
Purchase Sale Sale after option exercise All abbreviations